Travere Share Price

Travere Share Price

NASDAQ: TVTX | Mid Cap | Healthcare
$50.55
-$0.59 (-1.14%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Travere Stock Performance

Open
$51.03
Prev. Close
$51.13
Circuit Range
N/A
Day Range
$49.80 - $51.33
Year Range
$22.59 - $68.55
Volume
55,707
Average Traded
$50.62

Travere Share Price Today

As of 19 November 2026, Travere Therapeutics, Inc.'s share price is $50.55. The stock opened at $51.03, compared to its previous close of $51.13. During today's trading session, Travere Therapeutics, Inc.'s share price traded between $49.80 and $51.33, with an average price of $50.56. Over the past 52 weeks, the stock has recorded a high of $68.55 and a low of $22.59. In terms of performance, Travere Therapeutics, Inc.'s share price has risen by 7.11% over the last six months and is up 42.60% on a year-on-year basis.

Travere Share Price Chart

Line chart of the Travere price trend over the selected period. The price fell overall, ranging from 49.80 to 51.31, ending at 50.55.
$49.80$51.33
L
Show Current Price
H

Travere Stock Fundamentals & Key Indicators

Market Cap
$4.51B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.27
Revenue (TTM)
$490.73B
Return On Equity (TTM)
-538.02%
Profit Margin
-5.21%
Debt to Equity
26.72
Quarterly Earnings Growth YoY
-2017.22%

Travere Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$129.69$127.20$169.58$224.56
Net Profit$2.73-$37.10-$34.80-$52.34
Net Profit Margin2.11%-29.17%-20.52%-23.31%
Income ChangeN/A-1458.97%6.20%-50.40%

Travere Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$109.46$145.24$233.18$490.73
Net Profit-$278.48-$111.40-$321.55-$25.55
Net Profit Margin-254.41%-76.70%-137.90%-5.21%
Income ChangeN/A60.00%-188.64%92.05%

Travere Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets167.63177.42172.14186.15
Current Assets437.57416.7616.78486.44
Total Assets605.19594.13788.91672.59
Non Current Liabilities330.46334.3410.2430.37
Current Liabilities159.9200.75177.91199.36
Total Liabilities490.36535.05588.1629.73
Shareholders' Equity114.8359.08200.8142.85

Travere Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating37.78-237.48-280.02-186.29
Investing27.8999.3355.78-32.55
Financing-33.47139.42218.75117.57

About Travere

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Travere Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$50.45
$50.56
+0.26%
Oct 2026
$58.65
$50.43
-14.48%
Sep 2026
$65.88
$58.97
-12.61%
Aug 2026
$53.63
$67.48
+20.67%
Jul 2026
$57.10
$55.92
-1.51%
Jun 2026
$46.74
$56.78
+20.32%
May 2026
$42.31
$47.19
+12.06%
Apr 2026
$30.19
$42.11
+41.78%
Mar 2026
$29.93
$29.70
-0.47%
Feb 2026
$31.32
$29.84
-4.05%
Jan 2026
$38.62
$31.10
-18.63%
Dec 2025
$34.88
$38.22
+7.83%

Travere Share Price FAQs